BACH1 and Parkinson disease: The study by Ahuja and co-workers [207] convincingly demonstrates that Bach1 ablation has a pronounced neuroprotective effect in MPTP-induced parkinsonism and that Bach1 inhibition could serve as a drug target to prevent PD pathology.